Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

Solid Biosciences (SLDB) Return on Capital Employed (2018 - 2024)

Solid Biosciences' Return on Capital Employed history spans 7 years, with the latest figure at 0.56% for Q3 2024.

  • For Q3 2024, Return on Capital Employed rose 9.0% year-over-year to 0.56%; the TTM value through Sep 2024 reached 0.56%, up 9.0%, while the annual FY2023 figure was 0.53%, 5.0% down from the prior year.
  • Return on Capital Employed for Q3 2024 was 0.56% at Solid Biosciences, down from 0.44% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.31% in Q2 2021 and bottomed at 2.88% in Q3 2020.
  • The 5-year median for Return on Capital Employed is 0.51% (2024), against an average of 0.77%.
  • The largest annual shift saw Return on Capital Employed crashed -175bps in 2020 before it soared 256bps in 2021.
  • A 5-year view of Return on Capital Employed shows it stood at 1.09% in 2020, then skyrocketed by 69bps to 0.33% in 2021, then tumbled by -60bps to 0.53% in 2022, then decreased by -22bps to 0.65% in 2023, then grew by 13bps to 0.56% in 2024.
  • Per Business Quant, the three most recent readings for SLDB's Return on Capital Employed are 0.56% (Q3 2024), 0.44% (Q2 2024), and 0.51% (Q1 2024).